BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34511980)

  • 1. Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis.
    Chen L; Yang Y; Wang X; Wang C; Lin W; Jiao Z; Wang Z
    Pharmgenomics Pers Med; 2021; 14():1093-1106. PubMed ID: 34511980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of drug combination on tacrolimus target dose in renal transplant patients with different
    Zhang SF; Tang BH; Wei AH; Du Y; Guan ZW; Li Y
    Xenobiotica; 2022 Mar; 52(3):312-321. PubMed ID: 35395919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients.
    Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X
    J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients.
    Du Y; Song W; Xiong X; Ge W; Zhu H
    Xenobiotica; 2022 Mar; 52(3):274-283. PubMed ID: 35502774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial dose optimization of tacrolimus for children with systemic lupus erythematosus based on the CYP3A5 polymorphism and coadministration with Wuzhi capsule.
    Chen X; Wang D; Xu H; Li Z
    J Clin Pharm Ther; 2020 Apr; 45(2):309-317. PubMed ID: 31755126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients: a population pharmacokinetic analysis.
    Zuo XC; Ng CM; Barrett JS; Luo AJ; Zhang BK; Deng CH; Xi LY; Cheng K; Ming YZ; Yang GP; Pei Q; Zhu LJ; Yuan H; Liao HQ; Ding JJ; Wu D; Zhou YN; Jing NN; Huang ZJ
    Pharmacogenet Genomics; 2013 May; 23(5):251-61. PubMed ID: 23459029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of initial dosing scheme of tacrolimus in pediatric refractory nephrotic syndrome patients based on CYP3A5 genotype and coadministration with wuzhi-capsule.
    Chen X; Wang DD; Xu H; Li ZP
    Xenobiotica; 2020 May; 50(5):606-613. PubMed ID: 31530218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacokinetic study of tacrolimus and
    Qu J; Bian R; Liu B; Chen J; Zhai J; Teng F; Guo W; Wei H
    Front Pharmacol; 2022; 13():956166. PubMed ID: 36188616
    [No Abstract]   [Full Text] [Related]  

  • 9. Prediction of tacrolimus and Wuzhi tablet pharmacokinetic interaction magnitude in renal transplant recipients.
    Chen P; Dai R; She Y; Fu Q; Huang M; Chen X; Wang C
    Clin Transplant; 2022 Dec; 36(12):e14807. PubMed ID: 36057787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study.
    Wang DD; Chen X; Li ZP
    J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients.
    Cheng F; Li Q; Wang J; Zeng F; Zhang Y
    J Clin Pharm Ther; 2021 Dec; 46(6):1636-1649. PubMed ID: 34342024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
    Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
    Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of tacrolimus in Chinese adult liver transplant patients.
    Teng F; Zhang W; Wang W; Chen J; Liu S; Li M; Li L; Guo W; Wei H
    Biopharm Drug Dispos; 2022 Apr; 43(2):76-85. PubMed ID: 35220592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese lung transplant recipients.
    Cai X; Song H; Jiao Z; Yang H; Zhu M; Wang C; Wei D; Shi L; Wu B; Chen J
    Eur J Pharm Sci; 2020 Sep; 152():105448. PubMed ID: 32621968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepar-protecting Wuzhi capsule on pharmacokinetics and dose-effect character of tacrolimus in healthy volunteers.
    Teng F; Wang W; Zhang W; Qu J; Liu B; Chen J; Liu S; Li M; Chen W; Wei H
    Biopharm Drug Dispos; 2022 Aug; 43(4):119-129. PubMed ID: 35180322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
    Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population pharmacokinetic model to predict the individual starting dose of tacrolimus in adult renal transplant recipients.
    Andrews LM; Hesselink DA; van Schaik RHN; van Gelder T; de Fijter JW; Lloberas N; Elens L; Moes DJAR; de Winter BCM
    Br J Clin Pharmacol; 2019 Mar; 85(3):601-615. PubMed ID: 30552703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wuzhi Tablet (
    Li J; Chen S; Qin X; Fu Q; Bi H; Zhang Y; Wang X; Liu L; Wang C; Huang M
    Drug Metab Dispos; 2017 Nov; 45(11):1114-1119. PubMed ID: 28864749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus Population Pharmacokinetic Model in Adult Chinese Patients with Nephrotic Syndrome and Dosing Regimen Identification Using Monte Carlo Simulations.
    Liao M; Wang M; Zhu X; Zhao L; Zhao M
    Ther Drug Monit; 2022 Oct; 44(5):615-624. PubMed ID: 36101928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics model and initial dose optimization of tacrolimus in children and adolescents with lupus nephritis based on real-world data.
    Chen X; Wang DD; Xu H; Li ZP
    Exp Ther Med; 2020 Aug; 20(2):1423-1430. PubMed ID: 32765671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.